These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 38828128)

  • 1. STAT3-induced upregulation of lncRNA TTN-AS1 aggravates podocyte injury in diabetic nephropathy by promoting oxidative stress.
    Wang W; Li Y; Zhu F; Huang Y
    Toxicol Res (Camb); 2024 Jun; 13(3):tfae079. PubMed ID: 38828128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of lncRNA-PAX8-AS1-N directly associated with VEGF/TGF-β1/8-OhdG enhances podocyte apoptosis in diabetic nephropathy.
    Shen Y; Tong ZW; Zhou Y; Sun Y; Xie Y; Li R; Liu H
    Eur Rev Med Pharmacol Sci; 2020 Jun; 24(12):6864-6872. PubMed ID: 32633379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sp1-mediated upregulation of Prdx6 expression prevents podocyte injury in diabetic nephropathy via mitigation of oxidative stress and ferroptosis.
    Zhang Q; Hu Y; Hu JE; Ding Y; Shen Y; Xu H; Chen H; Wu N
    Life Sci; 2021 Aug; 278():119529. PubMed ID: 33894270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA ANRIL Silencing Alleviates High Glucose-Induced Inflammation, Oxidative Stress, and Apoptosis via Upregulation of MME in Podocytes.
    Cai R; Jiang J
    Inflammation; 2020 Dec; 43(6):2147-2155. PubMed ID: 32617859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA 1500026H17Rik knockdown ameliorates high glucose-induced mouse podocyte injuries through the miR-205-5p/EGR1 pathway.
    Xia J; Sun W; Dun J
    Int Urol Nephrol; 2023 Apr; 55(4):1045-1057. PubMed ID: 36306049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA SNHG16 Aggravates High Glucose-Induced Podocytes Injury in Diabetic Nephropathy Through Targeting miR-106a and Thereby Up-Regulating KLF9.
    He X; Zeng X
    Diabetes Metab Syndr Obes; 2020; 13():3551-3560. PubMed ID: 33116706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Triptolide inhibits oxidative stress and inflammation via the microRNA-155-5p/brain-derived neurotrophic factor to reduce podocyte injury in mice with diabetic nephropathy.
    Gao J; Liang Z; Zhao F; Liu X; Ma N
    Bioengineered; 2022 May; 13(5):12275-12288. PubMed ID: 35603354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin 37 (IL-37) Reduces High Glucose-Induced Inflammation, Oxidative Stress, and Apoptosis of Podocytes by Inhibiting the STAT3-Cyclophilin A (CypA) Signaling Pathway.
    Zhang X; Zhu Y; Zhou Y; Fei B
    Med Sci Monit; 2020 Sep; 26():e922979. PubMed ID: 32931486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isorhapontigenin ameliorates high glucose-induced podocyte and vascular endothelial cell injuries via mitigating oxidative stress and autophagy through the AMPK/Nrf2 pathway.
    Tian H; Zheng X; Wang H
    Int Urol Nephrol; 2023 Feb; 55(2):423-436. PubMed ID: 35960477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. lncRNA MSC-AS1 Aggravates Diabetic Nephropathy by Regulating the miR-325/CCNG1 Axis.
    Zhao H; Cui Y; Dong F; Li W
    J Healthc Eng; 2022; 2022():2279072. PubMed ID: 35126911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The protective effect and mechanism of catalpol on high glucose-induced podocyte injury.
    Chen Y; Liu Q; Shan Z; Zhao Y; Li M; Wang B; Zheng X; Feng W
    BMC Complement Altern Med; 2019 Sep; 19(1):244. PubMed ID: 31488111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA TTN-AS1 exacerbates extracellular matrix accumulation via miR-493-3p/FOXP2 axis in diabetic nephropathy.
    Jia L; Wang W; Liu H; Zhu F; Huang Y
    J Genet; 2023; 102():. PubMed ID: 36722214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. cAMP-response element binding protein mediates podocyte injury in diabetic nephropathy by targeting lncRNA DLX6-AS1.
    Zheng W; Guo J; Lu X; Qiao Y; Liu D; Pan S; Liang L; Liu C; Zhu H; Liu Z; Liu Z
    Metabolism; 2022 Apr; 129():155155. PubMed ID: 35093327
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Liu X; Jiang L; Zeng H; Gao L; Guo S; Chen C; Liu X; Zhang M; Ma L; Li Y; Qi X; Wu Y
    Autophagy; 2024 May; 20(5):1072-1097. PubMed ID: 38050963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulating lncRNA MIAT attenuates apoptosis of podocytes exposed to high glucose.
    Xia J; Huang Y; Ma M; Liu F; Cao B
    Acta Diabetol; 2024 Apr; 61(4):451-460. PubMed ID: 38072843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lycopene attenuates high glucose-mediated apoptosis in MPC5 podocytes by promoting autophagy via the PI3K/AKT signaling pathway.
    Wang Q; Li R; Xiao Z; Hou C
    Exp Ther Med; 2020 Sep; 20(3):2870-2878. PubMed ID: 32765784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA MALAT1/microRNA let-7f/KLF5 axis regulates podocyte injury in diabetic nephropathy.
    Zhang H; Yan Y; Hu Q; Zhang X
    Life Sci; 2021 Feb; 266():118794. PubMed ID: 33232688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective Role of lncRNA TTN-AS1 in Sepsis-Induced Myocardial Injury Via miR-29a/E2F2 Axis.
    Pei X; Wu Y; Yu H; Li Y; Zhou X; Lei Y; Lu W
    Cardiovasc Drugs Ther; 2022 Jun; 36(3):399-412. PubMed ID: 34519914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long noncoding RNA MEG3 suppresses podocyte injury in diabetic nephropathy by inactivating Wnt/β-catenin signaling.
    Che X; Deng X; Xie K; Wang Q; Yan J; Shao X; Ni Z; Ying L
    PeerJ; 2019; 7():e8016. PubMed ID: 31799068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA Hoxb3os protects podocytes from high glucose-induced cell injury through autophagy dependent on the Akt-mTOR signaling pathway.
    Jin J; Gong J; Zhao L; Li Y; He Q
    Acta Biochim Pol; 2021 Oct; 68(4):619-625. PubMed ID: 34648253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.